MedPath
FDA Approval

CHOLESTYRAMINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Cholestyramine(4 g in 9 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Zydus Lifesciences Limited

918596198

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zydus Lifesciences Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited

677605858

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CHOLESTYRAMINE

Product Details

NDC Product Code
70771-1105
Application Number
ANDA202901
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 9, 2024
Code: 4B33BGI082Class: ACTIBQuantity: 4 g in 9 g
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
VANILLAInactive
Code: Q74T35078HClass: IACT
© Copyright 2025. All Rights Reserved by MedPath